Marta Wawrzynowicz‐Syczewska

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska et al. · Alimentary Pharmacology & Therapeutics · 2016 · 99 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Interleukin‐1, interleukin‐10 and tumour necrosis factor‐alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha‐interferon therapy

P.K. Constantini, Marta Wawrzynowicz‐Syczewska, C. Michael et al. · Liver International · 2002 · 81 citations · Full text

Life Sciences, Genetics, Immunology +17

The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study

Katelynn S. Madill-Thomsen, Marwan Abouljoud, Chandra Bhati et al. · American Journal of Transplantation · 2020 · 52 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Risk factors and dynamics of weight gain in patients after liver transplantation.

Marta Wawrzynowicz‐Syczewska, E. Karpińska, Krzysztof Jurczyk et al. · PubMed · 2009 · 50 citations

Medicine, Surgery, Exercise Physiology +12

HLA class II genotypes associated with chronic hepatitis C virus infection and response to α‐interferon treatment in Poland

Marta Wawrzynowicz‐Syczewska, James A. Underhill, Michael Clare et al. · Liver International · 2000 · 42 citations

Life Sciences, Genetics, Immunology +17